Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

27.94
-0.1500-0.53%
Post-market: 27.960.0200+0.07%19:56 EST
Volume:3.19M
Turnover:88.37M
Market Cap:3.14B
PE:-27.70
High:28.30
Open:28.18
Low:26.97
Close:28.09
Loading ...
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 22, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Mar 26, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Major Issues Report

Form 8-K - Current report